Mabvax Therapeutics Holdings Inc (MBVX) Stock Price & Overview

NASDAQ:MBVX

Current stock price

0.46
-0.69 (-60%)
Last:

The current stock price of MBVX is 0.46 null. Today MBVX is down by -60%. In the past month the price decreased by -45.88%. In the past year, price decreased by -52.08%.

MBVX Key Statistics

52-Week Range0.43 - 2.6
Current MBVX stock price positioned within its 52-week range.
1-Month Range0.45 - 2.55
Current MBVX stock price positioned within its 1-month range.
Market Cap
4.122M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-10.92
Dividend Yield
N/A

MBVX Stock Performance

Today
-60%
1 Week
-23.33%
1 Month
-45.88%
3 Months
-69.93%
Longer-term
6 Months -47.73%
1 Year -52.08%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

MBVX Stock Chart

Mabvax Therapeutics Holdings Inc / MBVX Daily stock chart

MBVX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to MBVX. When comparing the yearly performance of all stocks, MBVX is a bad performer in the overall market: 98.75% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
MBVX Full Technical Analysis Report

MBVX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to MBVX. MBVX may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MBVX Full Fundamental Analysis Report

MBVX Earnings

Next Earnings DateN/A
Last Earnings DateN/A
MBVX Earnings History

MBVX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y72.44%
Revenue Next YearN/A
MBVX Forecast & Estimates

MBVX Financial Highlights

Over the last trailing twelve months MBVX reported a non-GAAP Earnings per Share(EPS) of -10.92. The EPS increased by 94.75% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-19.02M
Industry RankSector Rank
PM (TTM) N/A
ROA -216.38%
ROE -1682.65%
Debt/Equity 1.47
Chartmill High Growth Momentum
EPS Q2Q%133.09%
Sales Q2Q%N/A
EPS 1Y (TTM)94.75%
Revenue 1Y (TTM)-100%
MBVX financials

MBVX Ownership

Ownership
Inst Owners0%
Shares8.96M
Float7.12M
Ins Owners10.85%
Short Float %N/A
Short RatioN/A
MBVX Ownership

About MBVX

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical-stage drug development company. It is focused on discovering and developing small molecule drugs to treat cancer. TELINTRA is the Company's lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. MabVax Therapeutics Holdings, Inc., formerly known as Telik, Inc., is based in San Diego, California.

Company Info

Mabvax Therapeutics Holdings Inc

11535 SORRENTO VALLEY ROAD SUITE 400

SAN DIEGO CA 92121

CEO: J. David Hansen

Phone: 858-259-9405

Mabvax Therapeutics Holdings Inc / MBVX FAQ

What does Mabvax Therapeutics Holdings Inc do?

MabVax Therapeutics Holdings, Inc. is a clinical-stage drug development company. It is focused on discovering and developing small molecule drugs to treat cancer. TELINTRA is the Company's lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. MabVax Therapeutics Holdings, Inc., formerly known as Telik, Inc., is based in San Diego, California.


What is the current price of MBVX stock?

The current stock price of MBVX is 0.46 null. The price decreased by -60% in the last trading session.


What is the dividend status of Mabvax Therapeutics Holdings Inc?

MBVX does not pay a dividend.


What is the ChartMill technical and fundamental rating of MBVX stock?

MBVX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.